BIOMAT Database Logo BIOMAT Database Logo

Oral administration of solubilized amphotericin B. 1961

H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ

UI MeSH Term Description Entries
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
Beneficial therapeutic effects of solubilized amphotericin B after oral administration in experimental coccidioidomycosis, histoplasmosis, and cryptococcosis in mice.
January 1959, Antibiotics annual,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
Formulation of amphotericin B as nanosuspension for oral administration.
March 2003, International journal of pharmaceutics,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
[Administration of amphotericin B].
March 1972, Mycopathologia et mycologia applicata,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
Studies on a new solubilized preparation of amphotericin B.
January 1957, Antibiotics annual,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration.
October 2011, Journal of biomedical nanotechnology,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
[Local administration of amphotericin B (fungizone syrup) in oral candidiasis].
February 1985, Shikai tenbo = Dental outlook,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
[The treatment of digestive candidoses by oral administration of amphotericin B].
January 1970, Therapie,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
[Treatment of intestinal Candida infestation with oral administration of amphotericin B].
July 1971, La Clinica terapeutica,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranes.
January 2006, Biochimica et biophysica acta,
H M KRAVETZ, and V T ANDRIOLE, and M A HUBER, and J P UTZ
[Effects of amphotericin B on experimental mouse trichophytosis in oral administration].
September 1971, Mykosen,
Copied contents to your clipboard!